SEC Form 4 · accession 0001225208-16-039977
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John H Weiland
Director
Period of report
Sep 30, 2016
Accepted (ET)
Oct 4, 2016 · 3:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitF2,F1 | — | Sep 30, 2016 | A | 304 | A | — | — | Common Stock | 304 | 23,176 | D |
Explanation of responses
- F1Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.